Yubo International Biotech Limited
YBGJ · OTC
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $18 | $28 | $1,383 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $442 | $345 | $560 | $432 |
| Inventory | $37 | $322 | $164 | $67 |
| Other Curr. Assets | $196 | $358 | $307 | $27 |
| Total Curr. Assets | $683 | $750 | $1,058 | $1,909 |
| Property Plant & Equip (Net) | $685 | $1,407 | $3,338 | $394 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $51 | $68 | $39 | $55 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $117 | $124 | $152 | $87 |
| Total NC Assets | $852 | $1,599 | $3,529 | $536 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,535 | $2,349 | $4,587 | $2,445 |
| Liabilities | – | – | – | – |
| Payables | $1,038 | $550 | $276 | $101 |
| Short-Term Debt | $368 | $400 | $766 | $315 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $424 | $460 | $485 | $769 |
| Other Curr. Liab. | $2,892 | $564 | $988 | -$9 |
| Total Curr. Liab. | $4,722 | $2,523 | $2,790 | $1,277 |
| LT Debt | $111 | $390 | $1,928 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $111 | $390 | $1,928 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $111 | $0 | $0 | $0 |
| Total Liabilities | $4,833 | $2,914 | $4,718 | $1,277 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $120 | $120 | $118 | $117 |
| Retained Earnings | -$6,661 | -$3,690 | -$2,485 | -$943 |
| AOCI | $127 | $70 | $118 | $2 |
| Other Equity | $2,989 | $2,935 | $2,118 | $1,992 |
| Total Equity | -$3,424 | -$565 | -$131 | $1,168 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $127 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,535 | $2,349 | $4,587 | $2,445 |
| Net Debt | $472 | $772 | $2,666 | -$1,067 |